GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Other Stockholders Equity

Egetis Therapeutics AB (OSTO:PLED BTA) Other Stockholders Equity : kr28.40 Mil (As of Mar. 2025)


View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Other Stockholders Equity?

Egetis Therapeutics AB's Other Stockholders Equity for the quarter that ended in Mar. 2025 was kr28.40 Mil.

Egetis Therapeutics AB's quarterly Other Stockholders Equity increased from Sep. 2024 (kr22.70 Mil) to Dec. 2024 (kr24.80 Mil) and increased from Dec. 2024 (kr24.80 Mil) to Mar. 2025 (kr28.40 Mil).

Egetis Therapeutics AB's annual Other Stockholders Equity increased from Dec. 2022 (kr6.10 Mil) to Dec. 2023 (kr16.70 Mil) and increased from Dec. 2023 (kr16.70 Mil) to Dec. 2024 (kr24.80 Mil).


Egetis Therapeutics AB Other Stockholders Equity Historical Data

The historical data trend for Egetis Therapeutics AB's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Other Stockholders Equity Chart

Egetis Therapeutics AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.45 1.30 6.10 16.70 24.80

Egetis Therapeutics AB Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.60 19.40 22.70 24.80 28.40

Egetis Therapeutics AB Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Egetis Therapeutics AB Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Egetis Therapeutics AB's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Egetis Therapeutics AB Business Description

Traded in Other Exchanges
Address
Grev Turegatan 11 C, Stockholm, SWE, 114 46
Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines